Identifying the genes for human hypertension

Nephrology Dialysis Transplantation

Volumn 11, Issue 4, 1996, Pages 575-586

  Hingorani, A D ^a   Brown, M J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Essential hypertension; Genetics; Mapping; Quantitative trait

Indexed keywords

BLOOD PRESSURE; GENE; GENE MAPPING; GENETIC MARKER; HUMAN; HYPERTENSION; MOLECULAR BIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0029966396     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027344     Document Type: Review

References (133)

1. Khaw K-T. Genetics and environment: Geoffrey Rose revisited. Lancet 1994; 343: 838-889
2. Macmahon S, Peto R, Cutler J et al. Blood pressure, stroke and coronary artery disease part I: prolonged differences in blood pressure - evidence from nine prospective observational studies corrected for regression dilution bias. Lancet 1990; 335: 765-774
3. Sever P, Beevers G, Bulpitt C et al. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. Br Med J 1993; 306: 983-987
4. Hamilton M, Pickering GW, Roberts JAF et al. The aetiology of essential hypertension I. The arterial pressure in the general population. Clin Sci 1954; 13: 11-35
5. Shaper AG. Cardiovascular disease in the tropics - III, blood pressure and hypertension. Br Med J 1972; 2: 805-807
6. Poulter NR, Khaw K-T, Hopwood BEC et al. The Kenyan Luo migration study: observations on the initiation of a rise in blood pressure. Br Med J 1990; 300: 967-971
7. Beilin LJ. Epitaph to essential hypertension - a preventable disorder of known aetiology. J Hypertens 1988; 6: 85-94
8. Rosner B, Hennekens CH, Kass EH et al. Age-specific correlation analysis of longitudinal blood pressure data. Am J Epidemiol 1977; 106: 306-313
9. Barker DJP, Bull AR, Osmond C et al. Fetal and placental size and the risk of hypertension in the adult. Br Med J 1990; 301: 259-262
10. Fall CHD, Vijayakumar M, Barker DJP, Osmond C, Duggleby S. Weight in infancy and prevalence of coronary heart disease in adult life. Br Med J 1995; 310. 17-19
11. Barker DJP, Gluckman PD, Godfrey KM et al. Fetal nutrition and cardiovascular disease in adult life. Lancet 1993; 341: 938-941
12. Ben-Shlomo, Davey-Smith G. Deprivation in infancy or adult life: which is more important for mortality risk? Lancet 1991; 337: 530-534
13. Kurtz TW. Genetic models of hypertension. Lancet 1994; 344: 167-168
14. Longini IM, Higgins MW, Hinton PC et al. Environmental and genetic sources of familial aggregation of blood pressure in Tecumseh Michigan. Am J Epidemiol 1984; 120: 131-144
15. Hunt SC, Hasstedt SJ, Kuida H et al. Genetic heritablity and common environmental components of resting and stressed blood pressures, lipid and body mass index in Utah pedigrees and twins. Am J Epidemiol 1989; 129: 625-638
16. Mongeau J-G, Biron P, Sing CF. The influence of genetics and household environment upon the variability of blood pressure: the Montreal adoption study. Clin Exp Hypertens [A] 1986; 8: 653-660
17. Ward R. Familial aggregation and genetic epidemiology of blood pressure. In: Laragh JH, Brenner BM, ed. Hypertension: pathophysiology, Diagnosis and Management. New York, Raven Press, 1990; 81-100
18. Monseau J-G Heredity and blood pressure. Semin Nephrol 1989; 9: 208-216
19. Schimkets RA, Warnock DG, Bositis CM et al. Liddle's syndrome: heritable hypertension caused by mutations in the β-subunit of the epithelial sodium channel. Cell 1994; 79: 407-414
20. Mulligan LM, Kwok JBJ, Healey CS et al. Germ-line mutation of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 1993; 363: 458-460
21. Brauch H, Kishida T, Glavac D et al. Von Hippel-Lindau (VHL) disease with phaeochromocytoma in the Black Forest region of Germany: evidence for a founder effect. Hum Genet 1995; 95: 551-556
22. Glucksmann-Kuis MA, Tayber O, Woolf EA et al. Polycystic kidney disease: the complete structure of the PKD 1 gene and its protein. Cell 1995; 81: 289-298
23. Helmberg A, Ausserer B, Kofler R. Frameshift by insertion of two base pairs in codon 394 of CYP11B1 causes congenital adrenal hyperplasia due to 11-β-hydroxylase deficiency J Clin Endocrinol Metab 1992; 75: 1278-1281
24. Lifton RP, Dluhy RG, Powers M et al. Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase. Nature Genet 1992; 2: 66-72
25. Jamieson A, Slutsker L, Inglis CG et al. Glucocorticoid-suppressible aldosteronism: effects of crossover site and parental origin of chimaeric sene on phenotypic expression. Clin Sci 1995; 88: 563-570
26. Stewart PM, Corrie JET, Shackleton CHL, Edwards CRW. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle. J Clin Invest 1988; 82: 340-349
27. Liddle GW, Bledsoe T, Coppage WS Jr. A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion. Assoc Am Phys 1963; 76: 199-213
28. Botero-Velez M, Curtis JJ, Warnock DG. Brief report: Liddle's syndrome revisited - a disorder of sodium transport in the distal tubule. N Engl J Med 1994; 330: 178-181
29. Cooper DN, Krawczak M. Human Mutation. BIOS Scientific Publishers, 1993. 25-29
30. Weber JL, May PE. Abundant class of DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet 1989; 44: 388-396
31. Gyapay G, Morisette J, Vignal A et al. The 1993-1994 Genethon human genetic linkage map. Nature Genet 1994; 7: 246-248
32. Reed PW, Davies JL, Copeman JB et al. Chromosome-specific microsatellite sets for semi-automated genome mapping. Nature Genet 1994; 7: 390-394
33. Lindpaintner KL. Genetic linkage analysis in hypertension. J Hypertens 1992; 10: 121-124
34. Lifton RP, Jeunemaitre X. Finding the genes that cause human hypertension. J Hypertens 1993; 10: 121-124
35. Morris BJ. Identification of essential hypertension genes. J Hypertens 1993; 11: 115-120
36. Kurtz TW, Spence MA. Genetics of essential hypertension. Am J Med 1993; 94: 77-84
37. Kurtz TW, St Lezin EM, Pravenec M. Genetic models of hypertension A. Development of hypertension strains. Textbook of Hypertension. Blackwell Scientific, Oxford, 1994; 441-454
38. Lathrop GM, Soubrier F. Genetic basis of hypertension. Curr Opin Nephrol Hypertens 1994; 3: 200-206
39. Deng AY, Rapp JP. Cosegregation of blood pressure with angiotensin converting enzyme and atrial natriuretic peptide receptor genes using Dahl salt-sensitive rats. Nature Genet 1992; 1: 267-272
40. Wagner J, Zeh K, Paul M. Transgenic rats in hypertension research. J Hypertens 1992; 10: 601-605
41. Mullins JJ, Mullins LJ Transgenes, hypotheses and hypertension. Hypertension 1994; 23: 428-430
42. Carpecchi MR. Altering the genome by homologous recombination. Science 1989, 244: 1288-1292
43. Sharp MGF, Mullins JJ. Loss of gene function methodology. J Hypertens 1993, 11: 339-343
44. Paul M, Franz W-F. Transgenic animal models for hypertension research. Trends Cardiovasc Med 1995; 5: 108-114
45. Mullins JJ, Peters J, Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 344: 541-544
46. Peters J, Munter K, Bader M et al. Increased adrenal renin in transgenic hypertensive rats TGR(mRen2)27 and its regulation by cAMP, angiotensin II and calcium. J Clin Invest 1993; 91: 742-747
47. Bader M, Zhao Y, Sander M et al. Role of tissue renin in the pathophysiology of hypertension in TGR(mRen2)27 rats. Hypertension 1992; 19: 681-686
48. Krege JH, John SWM, Langenbach LL et al. Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature 1995; 375: 146-148
49. Wielbo D, Sernia C, Gyurko R, Phillips MI. Antisense inhibition of hypertension in the spontaneously hypertensive rat. Hypertension 1995; 25: 314-319
50. Lander ES, Schork NJ. Genetic dissection of complex traits. Science 1994; 265: 2037-2048
51. Bianchi G, Cusi D. The α-adducin polymorphism: a paradigm to analyse the genetics of primary hypertension. Nephrol Dialysis Transplant 1995; 10: 763-766
52. Williams RR, Hunt SC, Hopkins PN et al. Evidence for single gene contributions to hypertension and lipid disturbances: definition, genetics and clinical significance. Clin Genet 1994; 46: 80-87
53. Harrap SB. Genetic approaches to hypertension. Textbook of Hypertension. Blackwell Scientific, Oxford, 1994; 504-518
54. Haseman JK, Elston RC. Behav Genet 1972; 2: 3
55. Weeks DE, Harby LD. The affected-pedigree-member method: power to detect linkage. Hum Hered 1995; 45: 13-24
56. Weeks DE, Lange K. The affected-pedigree-member method of linkage analysis. Am J Hum Genet 1988; 42: 315-326
57. Risch N, Zhang H. Extreme discordant sib pairs for mapping quantitative trait loci in humans. Science 1995; 268: 1584-1589
58. Herrera VLM, Ruiz-Opazo N. Beyond genetic markers: hypertension genes. J Hypertens 1994; 12: 847-856
59. Prosser J. Detecting single base substitutions. TIBTECH 1993; 11: 238-246
60. Grompe M. The rapid detection of unknown mutations in nucleic acids. Nature Genet 1993; 5: 111-117
61. Folkow B. Cardiovascular structural adaptation: its role in the initiation and maintainence of primary hypertension. Clin Sci 1978; 55: 3-22S
62. Hughes AD, Schachter M. Hypertension and blood vessels. Br Med Bull 1994; 50: 356-370
63. Alderman MH, Madhavan S, Ooi WL et al. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med 1991; 324: 1098-1104
64. Rapp JP, Wang S-M, Dene H. A genetic polymorphism in the renin gene of Dahl rats cosegregates with blood pressure. Science 1989; 242: 542-544
65. Kurtz TW, Simonet L, Kabra KM et al. Cosegregation of the renin allele of the spontaneously hypertensive rat with an increase in blood pressure. J Clin Invest 1990; 85: 1328-1332
66. Soubrier F, Jeunemaitre X, Rigat B et al. Similar frequencies renin gene restriction fragment length polymorphisms in hypertensive and normotensive subjects. Hypertension 1990; 16: 712-717
67. Zee RYL, Ling LH, Morris BJ et al. Association and linkage analysis of restriction fragment length polymorphisms for the renin and antithrombin III genes in essential hypertension. J Hypertens 1991; 9: 825-830
68. Jeunemaitre X, Rigat B, Charru A et al. Sib pair linkage analysis of renin gene haplotypes in human essential hypertension. Hum Genet 1992; 88: 301-306
69. Alam KY, Wang Y, Dene H, Rapp JH. Renin gene nucleotide sequence of coding and regulatory regions in Dahl rats. Clin Exp Hypertens 1993; 15: 599-614
70. Walker WG, Whelton PK, Saito H. Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension 1979; 1: 287-291
71. Fasola AF, Martz BL, Helner OM. Plasma renin activity during supine exercise in offspring of hypertensive patients. J Appl Physiol 1968; 25: 410-415
72. Kimura S, Mullins JJ, Banneman B et al. High blood pressure in transgenic mice carrying the angiotensinogen gene. EMBO J 1992; 11: 821-827
73. Jeunemaitre X, Soubrier F, Kotelevtsev Y et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71: 169-180
74. Caulfield M, Lavender P, Farrall M et al. Linkage of the angiotensinogen gene with essential hypertension. N Engl J Med 1994; 330: 1629-1633
75. Hata A, Namikawa C, Sasaki M et al. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 1994; 93: 1285-1287
76. 235→THR variant of angiotensinogen in severe, familial hypertension. Biochem Biophys Res Comm 1993; 197: 833-839
77. Rotimi C, Morrison L, Cooper R et al. Angiotensinogen gene in human hypertension Lack of an association of the T235 allele among African Americans. Hypertension 1994; 24: 591-594
78. Bloem LJ, Manatunga A, Tewkesbury DA, Pratt JH. The serum angiotensinogen concentration and variants of the angiotensinogen gene in black and white children. J Clin Invest 1995; 95: 948-953
79. Amgrimsson R, Walker JJ, Soubrier F et al. Angiotensinogen: a candidate gene involved in pre-eclampsia. Nature Genet 1993; 4: 114-115
80. Pfeffer MA, Pfeffer JM. Reversing cardiac hypertrophy in hypertension. N Engl J Med 1990; 322: 1388-1390
81. Pfeffer MA, Braunwal E, Moye LA et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement trial. N Engl J Med 1992; 327: 669-677
82. Rigat B, Hubert C, Alhenc-Gelas F et al. An insertion/deletion polymorphism in the angiotensin-I converting enzyme gene accounting for half the variance of serum ACE levels. J Clin Invest 1990; 86: 1343-1346
83. Costerousse O, Allegrini, Lopez M, Alhenc-Gelas. Angiotensin-I converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 1993; 290: 33-40
84. Cambien F, Poirier O, Lecerf L, Evans A et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-644
85. Mattu R, Needham EWA, Galton DJ et al. A DNA variant at the angiotensin-converting enzyme locus associates with coronary artery disease in the Caerphilly Heart Study Circulation 1995; 91. 270-274
86. Schunkert H, Hense H-W, Holmer SR et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994; 330: 1634-1638
87. Evans AE, Poirier O, Kee F et al. Polymorphisms of the angiotensin converting enzyme gene in subjects who die from coronary heart disease. Q J Med 1994; 87: 211-214
88. Friedl W, Kremple F, Paulweber B, Pichler M, Sandhofer F. A deletion polymorphism in the angiotensin converting enzyme gene is not associated with coronary artery disease in an Austrian population. Atherosclerosis 1995; 112: 137-143
89. Lindpaintner K, Pfeffer MA, Kreutz R et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischaemic heart disease. N Engl J Med 1995; 332: 706-711
90. Jeunemaitre X, Lifton RP, Hunt SC et al. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nature Genet 1992; 1: 72-75
91. Schmidt S, van Hooft IMS, Grobbee DE, Ganten D, Ritz E. Polymorphism of the angiotensin I converting enzyme is apparently not related to high blood pressure: Dutch Hypertension and Offspring study. J Hypertens 1993; 11: 345-348
92. Zee RYL, Lou Y-k, Morris BJ. Association of a polymorphism of the angiotensin I converting enzyme gene with essential hypertension. Biochem Biophys Res Comm 1991; 184: 9-15
93. Morris BJ, Zee RYL, Schrader AP. Different frequencies of angiotensin-converting enzyme genotypes in older hypertensive individuals. J Clin Invest 1994; 94: 1085-1089
94. Hilbert P, Lindpaintner K, Beckmann JS et al. Chromosomal mapping of the genetic loci associated with blood pressure regulation in hereditary hypertensive rats. Nature 1991; 353: 521-529
95. Jacob HK, Lindpaintner K, Lincoln SE et al. Genetic mapping of a gene causing hypertension in the stroke prone spontaneously hypertensive rat. Cell 1991; 67: 213-224
96. Timmermans PBMW, Wong PC, Chiu AT et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993; 45: 206-251
97. Bonnardeaux A, Davies E, Jeunemaitre X et al. Angiotensin II type 1 receptor gene in essential hypertension. Hypertension 1994; 24: 63-69
98. Tiret L, Bonnardeaux A, Poirier O et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 1994; 344: 910-913
99. Haynes WG. Endothelins as regulators of vascular tone in man. Clin Sci 1995; 88: 509-517
100. Remuzzi G, Benigni A Endothelins in the control of cardiovascular and renal function. Lancet 1993; 342: 589-593
101. Karet FE, Davenport A. Endothelin and the kidney: a potential target for new drugs. Nephrol Dialysis Transplant 1994; 9: 465-468
102. Vanhoutte PM. Is endothelin involved in the pathogenesis of hypertension? Hypertension 1993; 21: 747-751
103. Haynes WG, Webb DJ. Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 1994; 344: 852-854
104. Deng AY, Dene H, Pravenec M et al. genetic mapping of two new blood pressure quantitative trait loci in the rat. J Clin Invest 1994; 93: 2701-2709
105. Cicila GT, Rapp JP, Bloch K et al. Cosegregation of the endothelin-3 locus with blood pressure and relative heart weight in inbred Dahl rats. J Hypertens 1994; 12: 643-651
106. Kurihara Y, Kurihara H, Suzuki H et al. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 1994; 368: 703-710
107. Sakao K, Ogawa Y, Suga S, Imura H. Molecular biology of the natruiretic peptide system I. Natriuretic peptides. J Hypertens 1992; 10. 907-912
108. Deag AY, Dene H, Rapp JP. Mapping of a quantitative trait locus for blood pressure on rat chromosome 2. J Clin Invest 1994; 94: 431-436
109. Barley J, Carter ND, Cruikshank JK et al. Renin and atrial natriuretic peptide gene polymorphisms: association with ethnicity and blood pressure. J Hypertens 1991; 9: 993-996
110. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiologv and pharmacology. Pharmacol Rev 1991; 43: 109-142
111. Hall AV, Antoniou H, Wang Y et al. Structural organisation of the human neuronal nitric oxide synthase gene. J Biol Chem 1994; 269: 33082-33090
112. Charles IG, Palmer RMJ, Hickery MS. Cloning characterisation and expression of a cDNA encoding an inducible nitric oxide synthase gene from the human chondrocyte. Proc Natl Acad Sci USA 1993; 90: 11419-11423
113. Marsden PA, Heng HHQ, Scherer SW et al. Structure and chromosomal localisation of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 1993; 268: 17478-17488
114. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; 2: 997-999
115. Haynes WG, Noon JP, Walker BR, Webb DJ. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertens 1993; 11: 1375-11380
116. !16. Otsuka Y, Dipiero A, Hirt E, Brennaman B, Lockette W. Vascular relaxation and cGMP in hypertension. Am J Physiol 1988; 254: H163-H169
117. Yagi A, Sato K, Ono Z. Exaggerated vascular response due to endothelial dysfunction and the role of the renin-angiotensin system at the early stage of renal hypertension in rats Circ Res 1994; 74: 130-138
118. Panza JA, Quyyumi AA, Brush JE, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22-27
119. G-monomethyl-L-arginine in patients with essential hypertension, the nitric oxide dilator mechanism appears abnormal. J Hypertens 1992; 10: 1025-1031
120. Cockcroft JR, Chowienczyk PJ, Benjamin N, Ritter JM. Preserved-endothelium-dependent vasodilatation in patients with essential hypertension. N Engl J Med 1994; 330: 1036-1040
121. Deng AY, Rapp JP. Locus for the inducible, but not a constitutive nitric oxide synthase cosegregates with blood pressure in the Dahl salt-sensitive rat. J Clin Invest 1995; 95: 2170-2177
122. Bonnardeaux A, Nadaud S, Charru A et al. Lack of evidence for linkage of the endothelial nitric oxide synthase gene to essential hypertension. Circulation 1995; 91: 96-102
123. Walker BR, Edwards CRW. New mechanisms for corticosteroid-induced hypertension. Br Med Bull 1994; 50: 342-355
124. Curnow K, Slutsker L, Vitek J et al. Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8. Proc Natl Acad Sci USA 1993; 90: 4552-4556
125. Cicila GT, Rapp JP, Wang JM et al. Linkage of 11β-hydroxylase mutations with altered steroid biosynthesis and blood pressure in the Dahl rat. Nature Genet 1993; 3: 346-353
126. Lifton RP, Dluhy RG, Powers M et al. A chimaeric 11β-hydroxylase aldosterone synthase gene causes glucocorticoid-remedial aldosteronism and human hypertension. Nature 1992; 355: 262-265
127. Iwai N, Inagami T. Isolation of preferentially expressed genes in the kidneys of hypertensive rats. Hypertension 1991; 17: 161-169
128. Samani NJ, Lodwick D, Vincent M et al. A gene differentially expressed in the kidney of the spontaneously hypertensive rat cosegregates with increased blood pressure. J Clin Invest 1993; 92: 1099-1103
129. Iwai N, Ohimichi N, Hanai K et al. Human SA gene locus as a candidate locus for essential hypertension. Hypertension 1994; 23: 375-380
130. Nabika T, Bonnardeaux A, James M et al. Evaluation of the SA locus in human hypertension. Hypertension 1995; 25: 6-13
131. Davies JL, Kawaguchi Y, Bennett ST et al. A genome-wide search for human type 1 diabetes susceptibility genes. Nature 1994; 371: 130-136
132. Hashimoto L, Habita S, Beressl JP et al. Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus. Nature 1994; 371: 161-164
133. Miki Y, Swensen J, Shattuck-Eidens D et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66-71